Alba Alfonso-Garcia

Dr. Alba Alfonso-Garcia

Biomedical Engineering Department, University of California, Davis, Davis, CA, USA
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 May 2015 in Scientific Reports
Verified
Journal Article
Open access
RDRupsa Datta
Rupsa Datta
AAAlba Alfonso-Garcia
Alba Alfonso-Garcia
RCRachel Cinco
Rachel Cinco
EGEnrico Gratton
Enrico Gratton
Presence of reactive oxygen species (ROS) in excess of normal physiological level results in oxidative stress. This can lead to a range of pathological conditions including inflammation, diabetes mellitus, cancer, cardiovascular and neurodegenerative disease. Biomarkers of oxidative stress play an important role in understanding the pathogenesis and treatment of these diseases. A number of fluorescent biomarkers exist. However, a non-invasive and label-free identification technique would be advantageous for in vivo measurements. In this work we establish a spectroscopic method to identify oxidative stress in cells and tissues by fluorescence lifetime imaging (FLIM). We identified an autofluorescent, endogenous species with a characteristic fluorescent lifetime distribution as a probe for oxidative stress. To corroborate our hypothesis that these species are products of lipid oxidation by ROS, we correlate the spectroscopic signals arising from lipid droplets by combining FLIM with THG and CARS microscopy which are established techniques for selective lipid body imaging. Further, we performed spontaneous Raman spectral analysis at single points of the sample which provided molecular vibration information characteristics of lipid droplets.

20 April 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
KJKaren R Jonscher
Karen R Jonscher
AAAlba Alfonso-Garcia
Alba Alfonso-Garcia
JSJeffrey L. Suhalim
Jeffrey L. Suhalim
DODavid J. Orlicky
David J. Orlicky
EPEric O. Potma
Eric O. Potma
MPMichael Pecaut
Michael Pecaut
Spaceflight affects numerous organ systems in the body, leading to metabolic dysfunction that may have long-term consequences. Microgravity-induced alterations in liver metabolism, particularly with respect to lipids, remain largely unexplored. Here we utilize a novel systems biology approach, combining metabolomics and transcriptomics with advanced Raman microscopy, to investigate altered hepatic lipid metabolism in mice following short duration spaceflight. Mice flown aboard Space Transportation System -135, the last Shuttle mission, lose weight but redistribute lipids, particularly to the liver. Intriguingly, spaceflight mice lose retinol from lipid droplets. Both mRNA and metabolite changes suggest the retinol loss is linked to activation of PPARα-mediated pathways and potentially to hepatic stellate cell activation, both of which may be coincident with increased bile acids and early signs of liver injury. Although the 13-day flight duration is too short for frank fibrosis to develop, the retinol loss plus changes in markers of extracellular matrix remodeling raise the concern that longer duration exposure to the space environment may result in progressive liver damage, increasing the risk for nonalcoholic fatty liver disease.

17 December 2015 in Journal of Biomedical Optics
Verified
Journal Article
Closed access
PDF file
AAAlba Alfonso-Garcia
Alba Alfonso-Garcia
SPSimon Pfisterer
Simon Pfisterer
HRHoward Riezman
Howard Riezman
EIElina Ikonen
Elina Ikonen
EPEric O. Potma
Eric O. Potma
We generated a highly deuterated cholesterol analog (D38-cholesterol) and demonstrated its use for selective vibrational imaging of cholesterol storage in mammalian cells. D38-cholesterol produces detectable signals in stimulated Raman scattering (SRS) imaging, is rapidly taken up by cells, and is efficiently metabolized by acyl-CoA cholesterol acyltransferase to form cholesteryl esters. Using hyperspectral SRS imaging of D38-cholesterol, we visualized cholesterol storage in lipid droplets. We found that some lipid droplets accumulated preferentially unesterified D38-cholesterol, whereas others stored D38-cholesteryl esters. In steroidogenic cells, D38-cholesteryl esters and triacylglycerols were partitioned into distinct sets of lipid droplets. Thus, hyperspectral SRS imaging of D38-cholesterol demonstrates a heterogeneous incorporation of neutral lipid species, i.e., free cholesterol, cholesteryl esters, and triacylglycerols, between individual lipid droplets in a cell.

18 April 2016 in Journal of Biomedical Optics
Verified
Journal Article
Open access
PDF file
AAAlba Alfonso-Garcia
Alba Alfonso-Garcia
TSTim D. Smith
Tim D. Smith
RDRupsa Datta
Rupsa Datta
TLThuy U. Luu
Thuy U. Luu
EGEnrico Gratton
Enrico Gratton
WLWendy F. Liu
Wendy F. Liu
Macrophages adopt a variety of phenotypes that are a reflection of the many functions they perform as part of the immune system. In particular, metabolism is a phenotypic trait that differs between classically activated, proinflammatory macrophages, and alternatively activated, prohealing macrophages. Inflammatory macrophages have a metabolism based on glycolysis while alternatively activated macrophages generally rely on oxidative phosphorylation to generate chemical energy. We employ this shift in metabolism as an endogenous marker to identify the phenotype of individual macrophages via live-cell fluorescence lifetime imaging microscopy (FLIM). We demonstrate that polarized macrophages can be readily discriminated with the aid of a phasor approach to FLIM, which provides a fast and model-free method for analyzing fluorescence lifetime images.

22 January 2018 in Hepatology Communications
Verified
Journal Article
Open access
PDF file
JFJacob E. Friedman
Jacob E. Friedman
EDEvgenia Dobrinskikh
Evgenia Dobrinskikh
AAAlba Alfonso-Garcia
Alba Alfonso-Garcia
AFAlexander Fast
Alexander Fast
RJRachel C. Janssen
Rachel C. Janssen
KJKaren R Jonscher
Karen R Jonscher
Increasingly, evidence suggests that exposure to maternal obesity creates an inflammatory environmentin utero, exerting long‐lasting postnatal signatures on the juvenile innate immune system and microbiome that may predispose offspring to development of fatty liver disease. We found that exposure to a maternal Western‐style diet (WD) accelerated fibrogenesis in the liver of offspring and was associated with early recruitment of proinflammatory macrophages at 8‐12 weeks and microbial dysbiosis as early as 3 weeks of age. We further demonstrated that bone marrow‐derived macrophages (BMDMs) were polarized toward an inflammatory state at 8 weeks of age and that a potent antioxidant, pyrroloquinoline quinone (PQQ), reversed BMDM metabolic reprogramming from glycolytic toward oxidative metabolism by restoring trichloroacetic acid cycle function at isocitrate dehydrogenase. This resulted in reduced inflammation and inhibited collagen fibril formation in the liver at 20 weeks of age, even when PQQ was withdrawn at 3 weeks of age. Beginning at 3 weeks of age, WD‐fed mice developed a decreased abundance ofParabacteroidesandLactobacillus, together with increasedRuminococcusand decreased tight junction gene expression by 20 weeks, whereas microbiota of mice exposed to PQQ retained compositional stability with age, which was associated with improved liver health.Conclusion: Exposure to a maternal WD induces early gut dysbiosis and disrupts intestinal tight junctions, resulting in BMDM polarization and induction of proinflammatory and profibrotic programs in the offspring that persist into adulthood. Disrupted macrophage and microbiota function can be attenuated by short‐term maternal treatment with PQQ prior to weaning, suggesting that reshaping the early gut microbiota in combination with reprogramming macrophages during early weaning may alleviate the sustained proinflammatory environment, preventing the rapid progression of nonalcoholic fatty liver disease to nonalcoholic steatohepatitis in offspring of obese mothers. (Hepatology Communications2018;2:313‐328)

22 December 2016 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
KJKaren R Jonscher
Karen R Jonscher
MSMichael S. Stewart
Michael S. Stewart
AAAlba Alfonso-Garcia
Alba Alfonso-Garcia
BDBrian C. DeFelice
Brian C. DeFelice
XWXiaoxin X. Wang
Xiaoxin X. Wang
JFJacob E. Friedman
Jacob E. Friedman
Nonalcoholic fatty liver disease (NAFLD) is widespread in adults and children. Early exposure to maternal obesity or Western‐style diet (WD) increases steatosis and oxidative stress in fetal liver and is associated with lifetime disease risk in the offspring. Pyrroloquinoline quinone (PQQ) is a natural antioxidant found in soil, enriched in human breast milk, and essential for development in mammals. We investigated whether a supplemental dose of PQQ, provided prenatally in a mouse model of diet‐induced obesity during pregnancy, could protect obese offspring from progression of NAFLD. PQQ treatment given pre‐ and postnatally in WD‐fed offspring had no effect on weight gain but increased metabolic flexibility while reducing body fat and liver lipids, compared with untreated obese offspring. Indices of NAFLD, including hepatic ceramide levels, oxidative stress, and expression of proinflammatory genes ( Nos2 , Nlrp3 , Il6 , and Ptgs2 ), were decreased in WD PQQ‐fed mice, concomitant with increased expression of fatty acid oxidation genes and decreased Pparg expression. Notably, these changes persisted even after PQQ withdrawal at weaning. Our results suggest that supplementation with PQQ, particularly during pregnancy and lactation, protects offspring from WD‐induced developmental programming of hepatic lipotoxicity and may help slow the advancing epidemic of NAFLD in the next generation. —Jonscher, K. R., Stewart, M. S., Alfonso‐Garcia, A., DeFelice, B. C., Wang, X. X., Luo, Y., Levi, M., Heerwagen, M. J. R., Janssen, R. C., de la Houssaye, B. A., Wiitala, E., Florey, G., Jonscher, R. L., Potma, E. O., Fiehn, O. Friedman, J. E. Early PQQ supplementation has persistent long‐term protective effects on developmental programming of hepatic lipotoxicity and inflammation in obese mice. FASEB J . 31, 1434–1448 (2017) www.fasebj.org